cdn mobile

DOH: Pregnant women now under A3 priority group for COVID-19 vaccination

By: Cathrine Gonzales - Reporter / @cgonzalesINQ - Inquirer.net | August 12,2021 - 12:06 PM

Inquirer.net stock photo

MANILA, Philippines — Pregnant women are now part of the expanded A3 priority group for COVID-19 vaccination, the Department of Health (DOH) said Thursday.

In a statement, Health Undersecretary Maria Rosario Vergeire said that based on the recommendation of local experts, COVID-19 vaccines are “generally safe” for pregnant women and that getting vaccinated against coronavirus is recommended during the second or third trimester of pregnancy.

Vergeire added that “high-risk” pregnant women in their first trimester may also be vaccinated provided that benefits and risks were fully explained to them and upon securing medical clearance from their doctor.

“We will be revising our existing guidelines for pregnant women based on these recommendations and to indicate that they are now part of Expanded A3,” she said.

Vergeire noted that most of the COVID-19 vaccines authorized in the country are safe for pregnant and breastfeeding women.

The only vaccine that should not be given to pregnant women is the Russian-made Sputnik V.

The announcement from DOH comes after the United States’ Centers for Disease Control and Prevention said that pregnant women should be vaccinated against COVID-19, based on a new analysis that did not show an increased risk for miscarriage.

gsg
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: pregnant women, Vergeire
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.